Print  Email
Interventional Cardiology Track AHA - ICT 2010
International


 


 

ICT - Program By Day (PDF)

ICT Mailer

ICT 2010 Mailer
View the brochure with page-turning technology for the most comprehensive and up-to-date information on the 2010 Interventional Cardiology Track at Scientific Sessions 2010.
View Mailer


Program Planner
Browse or search sessions, presentations or speakers.
View Planner

PCI

The American Heart Association’s (AHA) Interventional Cardiology Track (ICT) has an audience of more than 1,000 interventional cardiologists each year with more than 40 percent of the attendees coming from outside of the United States. Given this large and global audience, the AHA’s three primary goals for the track are to 1) select the best abstracts to show the state of the interventional cardiology field in research; 2) present and discuss the latest clinical trials that are changing our clinical practice right now; and 3) demonstrate the challenging art of interventional cardiology via case presentations, debates and discussions with a select group of international thought leaders. AHA dedicates ICT programming on Saturday through Wednesday morning to bring the full coronary, endovascular and structural heart interventional experience to our attendees. The connection between the art and science of interventional cardiology cannot come through lectures alone; so our program also includes many hours of debates, highlights, controversies, ask-the-expert programs, as well as an array of complex case presentations to allow our outstanding faculty to present the most current advances in the field. 

Learing Objectives: After completing this program, participants will be able to:

  1. Identify patients eligible for clinical trials, registries or future routine clinical care of aortic valve disease utilizing either conventional surgical or novel percutaneous technology.
  2. Review the current trial data distinguishing first, second and third generation drug eluting stents and determine the impact of this data on current clinical practice.
  3. Identify risk factors for bleeding complications during coronary intervention and the potential role of the radial approach, closure devices and specific pharmacologic strategies in reducing these complications.
  4. Determine the current role of stents, atherectomy and balloon angioplasty in treatment of patients with iliofemoral arterial disease.
  5. Understand the impact of the recent carotid stent trial data on selection of patients for percutaneous carotid intervention
  6. List the treatment, pharmacologic and transfer options that may be included in any regional STEMI algorithm
  7. Describe the potential treatment of complex structural heart disease with percutaneous solutions including left atrial appendage occlusion, valvular heart disease and septal defects.
  8. Identify the risk of stent thrombosis associated with non-cardiac surgery and controversies in treatment with dual antiplatelet therapy related to modification of stent thrombosis risk
  9. Review the current role of stent placement in treatment of high risk coronary anatomy including vein graft disease, bifurcation lesions and left main stenosis.
  10. Identify gaps in clinical practice and trial data that may impact the decision for surgical versus medical versus stent based treatment of multivessel coronary artery disease, left main disease, iliofemoral arterial disease and carotid artery disease.

Target Audience: The ICT 2010 track is for interventional cardiologists, radiologists, clinical cardiologists, basis scientists, vascular medicine specialists, surgeons, cath lab technicians and other healthcare professionals including medical students and trainees, nurse practitioners, physician assistants, nurses and technicians with special interest in the field of interventional and vascular medicine.

37725
"Great science is the standard at the AHA. Now, we can also learn the state of the art for interventional cardiologists in just four days of dedicated programming from the best international interventional cardiology faculty. This is a real opportunity to stay current and move ahead in our ever changing field."

Harry Dauerman, M.D., FAHA
ICT 2010 Chair
Interventional Cardiologist  
Professor of Medicine
Director, Cardiovascular
Catheterization Laboratories
University of Vermont

Join or renew your AHA/ASA Professional Membership today and save up to $370 on registration fees.  Experience the many benefits membership has to offer all year.*
Join or Renew   |   Member Benefits

*Specific benefits depends upon membership tier.